Latest Articles
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides - Nature.com
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides Nature.com
Published: Dec. 21, 2024, 9:20 a.m.
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer - Nature.com
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer Nature.com
Published: Dec. 20, 2024, 10:34 a.m.
Lunresertib Plus Camonsertib Produces Durable Responses in Advanced Endometrial, Ovarian Cancer - OncLive
Lunresertib Plus Camonsertib Produces Durable Responses in Advanced Endometrial, Ovarian Cancer OncLive
Published: Dec. 19, 2024, 4:30 p.m.
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion - MSN
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion MSN
Published: Dec. 19, 2024, 1:50 p.m.
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today
Published: Dec. 18, 2024, 8:16 p.m.
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer - Medpage Today
ASCO Reading Room | The Evolving Treatment Landscape for High-Risk Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:59 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Molecular Classification Drives Advances in Endometrial Cancer Treatment - Journal of Clinical Pathways
Molecular Classification Drives Advances in Endometrial Cancer Treatment Journal of Clinical Pathways
Published: Dec. 17, 2024, 3:25 p.m.
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission MSN
Published: Dec. 17, 2024, 1:27 p.m.
Link copied to clipboard!